Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
AEROSOL AND AIR QUALITY RESEARCH ; 22(7), 2022.
Article in English | Web of Science | ID: covidwho-1911888

ABSTRACT

The COVID-19 pandemic introduced considerable challenges for respiratory protection of different population groups. Disposable medical masks and NIOSH-approved N95 filtering facepiece respirators (FFRs) are typically their only defense against the virus. At the same time, continuous wearing of these devices, especially some N95 FFR models cause damage to the facial skin, such as skin irritation, swelling, and scaling. Skin protectants are becoming increasingly popular and effective in providing a protective barrier for the skin that reduces direct contact between a wearer???s face and respirator. Recent pilot studies involving human subjects have examined the effect of skin protectants on the performance of respirators/masks through fit testing, but their findings are heavily impacted by between-subject variability. This investigation deployed a standardized protocol that utilized the NIOSH advanced static manikin headform connected to a Breathing Recording and Simulation System (BRSS), producing a predetermined breathing pattern. The effect of skin protectants on the total inward leakage (TIL) was evaluated for three N95 FFR models, five different skin protectants, and two breathing flow rates. The aerosol particle concentrations inside and outside the respirator were measured with NaCl serving as the challenge aerosol. The TIL was shown to be significantly affected by the interaction of the skin protectant type, breathing flow rate and FFR models. The data suggest that different skin protectants may influence the performance of disposable N95 FFRs in different ways - by either increasing or decreasing the TIL value relative to one with no skin protectants applied. No negative effects on the TIL was observed for either tape- or gel/cream-type protectants when testing with 3M 8210 or 3M 1870+ FFRs;however, the use of skin protectants of either group with the AOSafety 1050 FFR may compromise its performance as quantified by the TIL.

2.
Aerosol and Air Quality Research ; 22(6):12, 2022.
Article in English | Web of Science | ID: covidwho-1869959

ABSTRACT

In spite of the remarkable progress made in the development of safe and effective vaccines against COVID-19, deployment of respiratory protective devices remains vital for mitigating the transmission of SARS-CoV-2 during the ongoing pandemic. In this study, we evaluated double masking, which entails layering a fitted over-mask on top of a surgical mask. A previously validated manikin-based protocol was used to evaluate the performance of a surgical mask with an over-mask made of silk or cotton. We showed that double masking can significantly enhance the mask???s source control capabilities by reducing an aerosol emission from a coughing or sneezing wearer while maintaining a reasonable breathability and comfort level. The data obtained in this study, as well as the results recently reported by other investigators, suggest that an over-mask made of silk fabric has several advantages over one made of cotton. Moreover, silk over-masks have the added benefit of providing a reusable protective outer layer for surgical masks as silk is hydrophobic and increases aerosol particle collection. Not only can double masking reduce viral or bacterial transmission, but it can also promote surgical mask longevity, thereby reducing global waste and pollution associated with the use of disposable surgical masks. Finally, an additional study with five human subjects revealed no significant differences in perceived comfort (measured by proxies such as relative humidity, temperature, and CO2 level inside the mask) between single masking and double masking, as well as between double masking with either a silk or cotton over-mask.

3.
J Hosp Infect ; 105(4): 608-614, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-619428

ABSTRACT

BACKGROUND: An exceptionally high demand for surgical masks and N95 filtering facepiece respirators (FFRs) during the COVID-19 pandemic has considerably exceeded their supply. These disposable devices are generally not approved for routine decontamination and re-use as a standard of care, while this practice has widely occurred in hospitals. The US Centers for Disease Control and Prevention allowed it "as a crisis capacity strategy". However, limited testing was conducted on the impact of specific decontamination methods on the performance of N95 FFRs and no data was presented for surgical masks. AIM: We evaluated common surgical masks and N95 respirators with respect to the changes in their performance and integrity resulting from autoclave sterilization and a 70% ethanol treatment; these methods are frequently utilized for re-used filtering facepieces in hospitals. METHODS: The filter collection efficiency and pressure drop were determined for unused masks and N95 FFRs, and for those subjected to the treatments in a variety of ways. The collection efficiency was measured for particles of approximately 0.037-3.2 µm to represent aerosolized single viruses, their agglomerates, bacteria and larger particle carriers. FINDINGS: The initial collection efficiency and the filter breathability may be compromised by sterilization in an autoclave and ethanol treatment. The effect depends on a protective device, particle size, breathing flow rate, type of treatment and other factors. Additionally, physical damages were observed in N95 respirators after autoclaving. CONCLUSION: Strategies advocating decontamination and re-use of filtering facepieces in hospitals should be re-assessed considering the data obtained in this study.


Subject(s)
Coronavirus Infections/prevention & control , Ethanol , Masks/standards , Occupational Exposure/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Respiratory Protective Devices/standards , Sterilization/standards , Ventilators, Mechanical/standards , Betacoronavirus , COVID-19 , Guidelines as Topic , Humans , SARS-CoV-2 , United States
SELECTION OF CITATIONS
SEARCH DETAIL